Fifty-three years ago today, one of the most impactful bluegrass guitarists in history died after being struck by a drunk ...

Tickets are almost sold out for the Gene Watson/Moe Bandy Living Legends Concert set for Saturday night at Love Civic Center.

For country music fans who love legendary performers Moe Bandy and Gene Watson Saturday night at the Live Civic Center was ...

And in the early 2000s, Paul Stanley and Gene Simmons, the leading figures and main songwriters in Kiss, were asked to name the debut albums they consider to be the greatest of all time. Inevitably, ...

Allison covers what hot startups are getting up to, and who’s financing them. She is also co-host of the weekly biotech podcast, “The Readout Loud.” You can reach Allison on Signal at AllisonDeAngelis ...

A new gene-editing company emerged from stealth on Tuesday with $230 million in committed financing, a reverse merger with a defunct oncology biotech, and a lead drug candidate licensed from a Chinese ...

The actress and activist spoke at a business forum for The Royal Foundation's United for Wildlife during London Climate Action Week on Monday, June 22 Emma Watson is stepping out for a good cause. The ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. The U.S. Air Force is investigating a decorated major who was arrested ...

The "Harry Potter" star was seen at an event also attended by Prince William and Benedict Cumberbatch. She was last on the big screen in 2019's "Little Women." Joey Nolfi is a senior writer at ...

When writing a blockbuster movie script, screenplay writers are sure to include all the essential elements of a hit film. In the biotech world, the launch of Serapha Bio seems to follow this formula, ...

Jason is a general assignment reporter, with particular focus on genetic medicine and rare disease. Confidential tips can be sent on Signal at JasonMast.77. David Meek bought Bluebird Bio last year ...

German drugmaker Merck KGaA said on Thursday it will acquire U.S. biotech firm Bio-Techne for $11.3 billion, its largest deal in over a decade, as it looks to strengthen its life sciences business.